JGC
RMD icon

J. Goldman & Co’s ResMed RMD Stock Holding History

J. Goldman & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,599
Closed -$4.39M – 610
2025
Q1 		$4.39M Buy
+19,599
New +$4.58M 0.11% 225

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

J. Goldman & Co's RMD Position: Q2 2025 in Review

J. Goldman & Co sold out of ResMed (RMD) in Q2 2025, closing a stake of 19,599 shares — an estimated $4.39M sold.

J. Goldman & Co first reported a position in RMD in Q1 2025 and held it in 1 quarter. The position peaked at $4.39M in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • J. Goldman & Co reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • J. Goldman & Co sold 19,599 ResMed shares in Q2 2025, an estimated $4.39M.
  • J. Goldman & Co first reported a position in ResMed in Q1 2025 and held it in 1 quarter.
  • J. Goldman & Co's ResMed position peaked at $4.39M in Q1 2025.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.